COMMUNIQUÉS West-GlobeNewswire

Neuronetics Reports Second Quarter 2019 Financial and Operating Results
06/08/2019
MALVERN, Pa., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life [...]
Kamada Reports Financial Results for Second Quarter and First Six Months of 2019
06/08/2019
Total Revenues for Second Quarter of 2019 were $35.3 Million, a 4% Increase Year-Over-Year Total Revenues for First Six Months of 2019 were $62.1 Million, a 21% Increase Year-Over-Year Gross Profit for Second Quarter [...]
BioCryst Reports Second Quarter 2019 Financial Results
06/08/2019
—New drug application for once-daily oral BCX7353 for prophylaxis of hereditary angioedema attacks on-track for submission in Q4 2019— —Data from ongoing Phase 1 trial of oral Factor D inhibitor, BCX9930, expected in Q4 [...]
Indus Holdings, Inc. to Present at the Canaccord Genuity 39th Annual Growth Conference
06/08/2019
SALINAS, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Indus Holdings, Inc. ("Indus") (CSE:INDS), a leading, vertically-integrated cannabis company, today announced that Co-founder and Chief Executive Officer Robert Weakley [...]
Evelo Biosciences Reports Positive EDP1815 Interim Clinical Data in Psoriasis Patients at Low Dose in Ongoing Phase 1b Trial
06/08/2019
-EDP1815 was Well Tolerated with No Overall Difference Reported from Placebo- -Patients Dosed with EDP1815 Showed a Reduction in Mean Lesion Severity Score vs. Placebo- -Reductions Observed in Cellular Histological and [...]
Orchard Therapeutics to Webcast Presentation at the 2019 Wedbush PacGrow Healthcare Conference
06/08/2019
BOSTON and LONDON, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life- [...]
G1 Therapeutics to Participate in BTIG and Wedbush Healthcare Conferences in August
06/08/2019
RESEARCH TRIANGLE PARK, N.C., Aug. 06, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that the company will participate in two investor conferences in [...]
Nabriva Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference
06/08/2019
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat [...]
GSK Grants Exclusive Technology License for Clinical-Stage Ebola Vaccines to Sabin Vaccine Institute
06/08/2019
Transfer from GSK and partnership with NIAID will enable Sabin to advance development of the candidate vaccines LONDON and WASHINGTON, Aug. 06, 2019 (GLOBE NEWSWIRE) -- GSK and the Sabin Vaccine Institute (Sabin) today [...]
Antares Pharma Reports Second Quarter 2019 Operating and Financial Results
06/08/2019
Record Quarterly Revenue of $28.4 Million - Double Second Quarter 2018 Revenue The Company Increases Full Year 2019 Revenue Guidance to a Range of $100.0 to $110.0 Million EWING, N.J., Aug. 06, 2019 (GLOBE NEWSWIRE) -- [...]
Neon Therapeutics Reports Second Quarter 2019 Financial Results
06/08/2019
Planning to present more detailed data from NT-001 clinical trial evaluating NEO-PV-01 in advanced or metastatic melanoma, non-small cell lung and bladder cancers at an upcoming medical society meeting Announces U.S. [...]
R1 RCM Reports Second Quarter 2019 Results
06/08/2019
CHICAGO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced results for the three months [...]
InspireMD Announces Second Quarter 2019 Financial Results
06/08/2019
U.S. Investigational Device Exemption (IDE) application submitted to FDA Company to host investor conference call today, August 6, at 8:00am ET TEL AVIV, Israel, Aug. 06, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE [...]
Oxford Immunotec Reports Second Quarter 2019 Financial Results
06/08/2019
Second quarter revenue of $19.6 million, an increase of 18% compared to prior year period Gross margin of 72.4%, reflecting our shift towards a pure-play kit business Positive net income of $0.6 million compared to a [...]
Dova Pharmaceuticals Reports Second Quarter 2019 Operating and Financial Results
06/08/2019
DOPTELET ® (avatrombopag) approved by U.S. Food and Drug Administration (FDA) for treatment of chronic immune thrombocytopenia (ITP); commercial launch occurred mid-July DOPTELET approved by European Commission (EC) for [...]
Vericel Reports Second Quarter 2019 Financial Results and Raises Full Year 2019 Revenue Guidance
06/08/2019
Record Second Quarter Product Revenues of $26.2 Million Represent a 38% Increase Over Second Quarter 2018 Full Year 2019 Revenue Guidance Raised to $112 to $116 Million Conference Call Today at 8:00am Eastern Time [...]
Aquinox Pharmaceuticals and Neoleukin Therapeutics announce merger agreement
06/08/2019
• Combined company capitalized with approximately $65M to develop novel immunotherapies • Sophisticated computational platform enables new class of de novo protein therapeutics • Lead program, NL-201, is a potent IL-2/ [...]
Evelo Biosciences Announces Positive Interim Phase 1b Clinical Data and Provides Second Quarter 2019 Financial Results
06/08/2019
-EDP1815 and EDP1066 were Well Tolerated with No Overall Difference Reported from Placebo- -Clinical Response Observed Consistent with Reductions in Cellular Histological and Blood Immune Cell Biomarkers in Psoriasis [...]
Emerald Health Therapeutics Outlines Production and Processing Advancements
06/08/2019
VICTORIA, British Columbia, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) today provided updates on its various cultivation and processing initiatives. “With [...]

Pages